A detailed history of Perceptive Advisors LLC transactions in Biodesix Inc stock. As of the latest transaction made, Perceptive Advisors LLC holds 2,173,880 shares of BDSX stock, worth $2.52 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
2,173,880
Previous 2,173,880 -0.0%
Holding current value
$2.52 Million
Previous $3.33 Million 16.33%
% of portfolio
0.1%
Previous 0.1%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.21 - $1.71 $2.63 Million - $3.72 Million
2,173,880 New
2,173,880 $3.33 Million

Others Institutions Holding BDSX

About BIODESIX INC


  • Ticker BDSX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 39,982,000
  • Market Cap $46.4M
  • Description
  • Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...
More about BDSX
Track This Portfolio

Track Perceptive Advisors LLC Portfolio

Follow Perceptive Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perceptive Advisors LLC with notifications on news.